share_log

Adicet Bio Analyst Ratings

Adicet Bio Analyst Ratings

Adicet 生物分析師評級
Benzinga ·  2023/11/09 10:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/09/2023 293.7% Wedbush $17 → $5 Maintains Outperform
09/06/2023 2025.98% Truist Securities → $27 Reiterates Buy → Buy
08/11/2023 1947.24% HC Wainwright & Co. $38 → $26 Maintains Buy
08/10/2023 687.4% BTIG $20 → $10 Maintains Buy
08/10/2023 1238.58% Wedbush → $17 Reiterates Outperform → Outperform
06/27/2023 1474.8% Guggenheim → $20 Downgrades Buy → Neutral
06/27/2023 2892.13% HC Wainwright & Co. → $38 Reiterates Buy → Buy
06/27/2023 — JMP Securities Downgrades Market Outperform → Market Perform
06/01/2023 372.44% JP Morgan $20 → $6 Downgrades Overweight → Neutral
05/15/2023 1396.06% JMP Securities → $19 Reiterates Market Outperform → Market Outperform
05/10/2023 2262.2% Wedbush → $30 Reiterates → Outperform
05/10/2023 2892.13% HC Wainwright & Co. → $38 Maintains Buy
03/16/2023 2262.2% Wedbush → $30 Reiterates → Outperform
03/16/2023 2892.13% HC Wainwright & Co. → $38 Reiterates → Buy
12/12/2022 2892.13% HC Wainwright & Co. $34 → $38 Maintains Buy
09/21/2022 1711.02% JP Morgan → $23 Initiates Coverage On → Overweight
03/31/2022 2104.72% SMBC Nikko → $28 Initiates Coverage On → Outperform
03/17/2022 1553.54% JMP Securities $30 → $21 Maintains Market Outperform
03/08/2022 2262.2% Truist Securities → $30 Initiates Coverage On → Buy
03/04/2022 2025.98% Jefferies → $27 Initiates Coverage On → Buy
12/06/2021 2419.69% Guggenheim $22 → $32 Maintains Buy
05/18/2021 2577.17% BTIG → $34 Initiates Coverage On → Buy
04/29/2021 2498.43% JonesTrading → $33 Initiates Coverage On → Buy
04/23/2021 2025.98% HC Wainwright & Co. → $27 Initiates Coverage On → Buy
04/14/2021 2104.72% Canaccord Genuity → $28 Initiates Coverage On → Buy
04/08/2021 1632.28% Guggenheim → $22 Initiates Coverage On → Buy
11/04/2020 2262.2% B. Riley Securities → $30 Initiates Coverage On → Buy
10/16/2020 1868.5% Wedbush → $25 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
11/09/2023 293.7% Wedbush 17 美元 → 5 美元 維護 跑贏大盤
09/06/2023 2025.98% Truist 證券 → 27 美元 重申 購買 → 購買
08/11/2023 1947.24% HC Wainwright & Co. 38 美元 → 26 美元 維護 買
08/10/2023 687.4% BTIG 20 美元 → 10 美元 維護 買
08/10/2023 1238.58% Wedbush → 17 美元 重申 跑贏大盤 → 跑贏大盤
06/27/2023 1474.8% 古根海姆 → 20 美元 降級 買入 → 中性
06/27/2023 2892.13% HC Wainwright & Co. → 38 美元 重申 購買 → 購買
06/27/2023 — JMP 證券 降級 市場跑贏大盤 → 市場表現
06/01/2023 372.44% 摩根大通 20 美元 → 6 美元 降級 超重 → 中性
05/15/2023 1396.06% JMP 證券 → 19 美元 重申 市場跑贏大盤 → 市場跑贏大盤
05/10/2023 2262.2% Wedbush → 30 美元 重申 → 跑贏大盤
05/10/2023 2892.13% HC Wainwright & Co. → 38 美元 維護 買
03/16/2023 2262.2% Wedbush → 30 美元 重申 → 跑贏大盤
03/16/2023 2892.13% HC Wainwright & Co. → 38 美元 重申 → 購買
2022 年 12 月 12 日 2892.13% HC Wainwright & Co. 34 美元 → 38 美元 維護 買
09/21/2022 1711.02% 摩根大通 → 23 美元 啓動覆蓋範圍開啓 → 超重
03/31/2022 2104.72% 三井住友銀行日光 → 28 美元 啓動覆蓋範圍開啓 → 跑贏大盤
03/17/2022 1553.54% JMP 證券 30 美元 → 21 美元 維護 市場表現跑贏大盤
03/08/2022 2262.2% Truist 證券 → 30 美元 啓動覆蓋範圍開啓 → 購買
03/04/2022 2025.98% 傑富瑞集團 → 27 美元 啓動覆蓋範圍開啓 → 購買
12/06/2021 2419.69% 古根海姆 22 美元 → 32 美元 維護 買
05/18/2021 2577.17% BTIG → 34 美元 啓動覆蓋範圍開啓 → 購買
04/29/2021 2498.43% JonesTrading → 33 美元 啓動覆蓋範圍開啓 → 購買
2021 年 4 月 23 日 2025.98% HC Wainwright & Co. → 27 美元 啓動覆蓋範圍開啓 → 購買
2021 年 4 月 14 日 2104.72% Canaccord Genu → 28 美元 啓動覆蓋範圍開啓 → 購買
2021 年 8 月 4 日 1632.28% 古根海姆 → 22 美元 啓動覆蓋範圍開啓 → 購買
11/04/2020 2262.2% B. 萊利證券 → 30 美元 啓動覆蓋範圍開啓 → 購買
10/16/2020 1868.5% Wedbush → 25 美元 啓動覆蓋範圍開啓 → 跑贏大盤

What is the target price for Adicet Bio (ACET)?

Adicet Bio（ACET）的目標價格是多少？

The latest price target for Adicet Bio (NASDAQ: ACET) was reported by Wedbush on November 9, 2023. The analyst firm set a price target for $5.00 expecting ACET to rise to within 12 months (a possible 293.70% upside). 15 analyst firms have reported ratings in the last year.

Wedbush於2023年11月9日公佈了Adicet Bio（納斯達克股票代碼：ACET）的最新目標股價。該分析公司將目標股價定爲5.00美元，預計ACET將在12個月內升至12個月內（可能上漲293.70％）。去年有15家分析公司公佈了評級。

What is the most recent analyst rating for Adicet Bio (ACET)?

分析師對Adicet Bio（ACET）的最新評級是多少？

The latest analyst rating for Adicet Bio (NASDAQ: ACET) was provided by Wedbush, and Adicet Bio maintained their outperform rating.

Wedbush提供了Adicet Bio（納斯達克股票代碼：ACET）的最新分析師評級，Adicet Bio維持了跑贏大盤的評級。

When is the next analyst rating going to be posted or updated for Adicet Bio (ACET)?

Adicet Bio（ACET）的下一個分析師評級何時公佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adicet Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adicet Bio was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Adicet Bio的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Adicet Bio的最新評級是在2023年11月9日發佈的，因此您應該預計下一個評級將在2024年11月9日左右公佈。

Is the Analyst Rating Adicet Bio (ACET) correct?

分析師對Adicet Bio（ACET）的評級正確嗎？

While ratings are subjective and will change, the latest Adicet Bio (ACET) rating was a maintained with a price target of $17.00 to $5.00. The current price Adicet Bio (ACET) is trading at is $1.27, which is out of the analyst's predicted range.

儘管評級是主觀的，並且會發生變化，但最新的Adicet Bio（ACET）評級保持不變，目標股價爲17.00美元至5.00美元。Adicet Bio（ACET）目前的交易價格爲1.27美元，超出了分析師的預期區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論